Chong Kun Dang Pharmaceutical (185750.KS) stock: key figures, P/E, revenue and dividend
Health Care · Pharmaceuticals · South Korea · ISIN KR7185750007
Chong Kun Dang Pharmaceutical financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 1.59 tn KRW | 1.69 tn KRW |
| Gross profit | 532.61 bn KRW | 526.38 bn KRW |
| Operating income | 99.46 bn KRW | 80.57 bn KRW |
| EBIT | 110.33 bn KRW | 88.35 bn KRW |
| Net income | 109.07 bn KRW | 77.51 bn KRW |
| Diluted EPS – continuing operations | 8,679.16 KRW | 5,882.52 KRW |
Full history since 2016, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Chong Kun Dang Pharmaceutical
Chong Kun Dang Pharmaceutical Corp. manufactures, markets, and sells medicines in South Korea and internationally. It offers prescription drugs for anti-hypertension, anti-hyperlipidaemia, and anti-diabetics, as well as immunosuppressants; over-the-counter medicines; and consumer health products, such as insecticides and hair dye products, as well as health supplements. The company was founded in 1941 and is headquartered in Seoul, South Korea.
More stocks
- ProFrac Holding Corp. (ACDC)
- Anhui Huaheng Biotechnology Co. Ltd. A (688639.SS)
- Shandong Ruifeng Chemical Co Ltd (300243.SZ)
- Taiwan Microloops Corp. (6831.TW)
- Ningbo Techmation Co Ltd (603015.SS)
- Minami Acoustics Ltd. A (301383.SZ)
- Suzhou Alton Electrical & Mechanical Industry Co. Ltd. (301187.SZ)
- Centrotec Se (CEV.HM)
- Molinos Agro SA (MOLA.BA)
- Beijing Career International Co Ltd (300662.SZ)
- Xiamen Anne Corp Ltd (002235.SZ)
- LivsMed (491000.KQ)
Not investment advice. All data without warranty, price as of 09.11.2026. Details in the risk notice.